Journal of Mosquito Research 2024, Vol.14, No.3, 111-123 http://emtoscipublisher.com/index.php/jmr 117 However, the vaccine's effectiveness varies, and it is not a standalone solution but rather a complementary tool to existing vector control methods (Achee et al., 2019). For other mosquito-borne diseases like dengue, vaccines such as Dengvaxia have been developed, but their use is limited by varying efficacy and safety concerns. 6.2.2 Emerging treatments and research Research is ongoing to develop new vaccines and treatments for mosquito-borne diseases. Novel approaches include the use of genetically modified mosquitoes to reduce disease transmission and the development of vaccines targeting multiple stages of the mosquito life cycle or multiple pathogens (Jones et al., 2020a). Additionally, new insecticides and drug formulations are being tested to overcome resistance issues and improve the effectiveness of existing interventions. 6.3 Community-based interventions and public education Community-based interventions and public education are crucial for the sustainable control of mosquito-borne diseases. These strategies involve educating communities about the importance of eliminating mosquito breeding sites, using protective measures like ITNs and IRS, and seeking timely medical treatment for symptoms of mosquito-borne diseases (Sherrard-Smith et al., 2019). Community engagement can enhance the effectiveness of vector control programs by ensuring local participation and compliance, thereby reducing disease transmission and improving public health outcomes. By integrating these prevention and control strategies, it is possible to achieve a more comprehensive and effective approach to managing mosquito-borne diseases globally. 7 Case Study 7.1 Case study 1: malaria control in Sub-Saharan Africa 7.1.1 Historical context and current trends Malaria has been a significant public health challenge in Sub-Saharan Africa for decades. Historically, the region has experienced high malaria transmission rates due to favorable climatic conditions for the Anopheles mosquito, the primary vector for malaria. Efforts to control malaria have seen varying degrees of success over the years. The introduction of artemisinin-based combination therapies (ACTs) and insecticide-treated bed nets (ITNs) in the early 2000s marked a turning point in malaria control efforts. These interventions, along with indoor residual spraying (IRS), have contributed to a significant decline in malaria incidence and mortality rates in the region (Benelli and Mehlhorn, 2016). Despite these successes, challenges remain. The emergence of insecticide resistance in mosquito populations and drug resistance in Plasmodium parasites pose significant threats to malaria control efforts. Additionally, socio-economic factors, such as poverty and limited access to healthcare, continue to hinder progress. 7.1.2 Intervention strategies and outcomes Several intervention strategies have been implemented to control malaria in Sub-Saharan Africa. These include the widespread distribution of ITNs, IRS, and the use of ACTs for treatment. Community-based interventions, such as health education and environmental management, have also played a crucial role in reducing malaria transmission (Benelli and Mehlhorn, 2016). The outcomes of these interventions have been promising. For instance, the use of ITNs has been associated with a significant reduction in malaria incidence and child mortality rates. IRS has also proven effective in reducing mosquito populations and interrupting malaria transmission. However, the sustainability of these interventions is threatened by the development of resistance to insecticides and antimalarial drugs. 7.2 Case study 2: dengue outbreak management in Southeast Asia 7.2.1 Regional epidemiology Dengue fever is a major public health concern in Southeast Asia, where it is considered the most important mosquito-borne viral disease (Guzmán et al., 2010). The region has experienced a significant increase in dengue incidence over the past few decades, with multiple dengue virus serotypes circulating simultaneously, leading to
RkJQdWJsaXNoZXIy MjQ4ODY0NQ==